Guidance for New CDAs/NDAs received by Emory Department of Pediatrics and Pediatric Institute Faculty
For new confidential disclosure agreements (CDA) and non-disclosure agreements (NDA), approval is required by the appropriate office (see CDA/NDA Routing Section below).
When you send an email, please remember to include the following information:
*For sending information about data sharing, indicate whether 1.) Emory will receive confidential information only OR 2.) Emory will share confidential information only OR 3.) Sponsor will share confidential information, and Emory will or may share confidential information.
CDA/NDA Routing
For industry clinical trials with a Children’s component (most will fit this), route to Children’s Office of Sponsored Programs
- Process: Send email with the CDA attached to Children's Office of Research Administration
For industry clinical trials without a Children’s component, route to Emory Office of Sponsored Programs (OSP)
- Process: Send email with agreement attached to Emory Office of Sponsored Programs
Route to Emory Office of Sponsored Programs (OSP).
- Process: Send email with agreement attached to Emory Office of Sponsored Programs
Route to Office of Technology Transfer (OTT)- including investigator-initiated studies
- Process: Send email with agreement attached to Emory Office of Technology Transfer
These need review by your Department and the Dean's office as an external activity
- Process: Submit the agreement as an external activity request in the Emory Electronic Conflict of Interest site
- You can view the eCOI submission instructions here.
*If the CDA or NDA does not appear to fit the above categories, contact Sarah Marie Huban.
Meet the Team
Claudia Morris, MD, FAAP
Center Director-CCTR
Sarah Marie Huban, MA, CIP, CHRC
Director, Clinical Trials
Mary Mungai
Manager, Clinical Trials
Mary Anne Geryak, M.S.
Program & Research Manager, CCTR and HeRO